HomeNewsWorldWHO calls on China to be transparent in sharing data to determine Covid's origins

WHO calls on China to be transparent in sharing data to determine Covid's origins

The Huanan market in central China’s Wuhan city was the epicentre of the pandemic. From its origin there, the SARS-CoV-2 virus rapidly spread to other locations in Wuhan in late 2019 and then to the rest of the world.

March 18, 2023 / 10:12 IST
Story continues below Advertisement
The coronavirus initially broke out in the central Chinese city of Wuhan in December 2019 (Representative image)
The coronavirus initially broke out in the central Chinese city of Wuhan in December 2019 (Representative image)

The WHO has criticised China for withholding data related to samples taken at a market in Wuhan in 2020 that could have provided vital information about the Covid-19 pandemic’s origins, calling on Beijing to be transparent and to share results of investigations it conducts.

The Huanan market in central China’s Wuhan city was the epicentre of the pandemic. From its origin there, the SARS-CoV-2 virus rapidly spread to other locations in Wuhan in late 2019 and then to the rest of the world.

Story continues below Advertisement

“Every piece of data relating to studying the origins of COVID-19 needs to be shared with the international community immediately. These data could have – and should have – been shared three years ago,” World Health Organisation (WHO) Director-General Dr Tedros Adhanom Ghebreyesus said in Geneva on Friday.

"We continue to call on China to be transparent in sharing data and to conduct the necessary investigations and share the results. Understanding how the pandemic began remains both a moral and scientific imperative,” he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show